A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

SilverScript, CVS Caremark’s Plan D provider has 3.4 million Medicare beneficiaries; Aetna’s Plan D provider has 750,000 beneficiaries. Both plans contract with CVS Caremark for pharmacy benefits ...

Medicare is investigating reports that CVS Caremark Corp., the country’s second-largest drugstore chain, has refilled prescriptions and submitted insurance claims without patients’ approval ...

An unsealed 2014 lawsuit by an Aetna actuary whistleblower against CVS Caremark, the insurer's pharmacy benefit manager, accuses the PBM of billing the government for prescription drugs at a greater ...

CVS Caremark Corp. is no stranger to government scrutiny. In recent years, the company has paid more than $80 million to resolve allegations of overbilling Medicaid, improperly changing patients ...

An Aetna actuary who accused CVS Caremark of a massive fraud scheme was placed on administrative leave days after she refused the insurer's request to destroy documents, according to her attorney.

> The U.S. Department of Health & Human Services has launched an investigation into whether CVS Caremark has defrauded Medicare by refilling prescriptions without patient approval and then ...

A huge whistleblower lawsuit has been filed against CVS Caremark, ... the fraud could impact many more. ... which happens to be one of the largest Medicare Drug clients of CVS Caremark.

CVS Health Corp's pharmacy benefit management unit has dodged a whistleblower lawsuit accusing it of multiple violations of the federal Medicare law, including approving claims for drugs without ...

CVS Caremark to pay $95M in Medicare fraud case A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for generic drugs.

CVS Caremark to pay $95M in Medicare fraud case. Sydney Halleman . Thu, Jun 26, 2025, 5:16 AM 2 min read. In This Article: CVS . This story was originally published on Healthcare Dive.

–CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.– ...